Key result
Transcatheter mitral valve repair was associated with a lower risk of all-cause mortality and heart failure hospitalization compared to medical management (HR 0.419, P=0.044).
Why the study?
Exercise-induced secondary mitral regurgitation carries a poor prognosis, but optimal therapeutic strategies remain to be investigated.
Does transcatheter mitral valve repair (TMVr) reduce the composite of all-cause mortality and heart failure hospitalization in patients with exercise-induced secondary mitral regurgitation compared to medical management?
Cohort (n=46)
Does transcatheter mitral valve repair (TMVr) reduce the composite of all-cause mortality and heart failure hospitalization in patients with exercise-induced secondary mitral regurgitation compared to medical management?
In patients with exercise-induced secondary mitral regurgitation, transcatheter mitral valve repair (TMVr) is associated with improved event-free survival compared to medical management alone.
TMVr was associated with lower event risk in exercise-induced secondary MR; leaves open whether randomized trials should confirm benefit before practice change.
AIMS: Although exercise-induced secondary mitral regurgitation (MR) is known to have a poor prognosis, the therapeutic strategy towards this condition remains to be investigated. In the present study, we aimed to investigate the prognostic impact of transcatheter mitral valve repair (TMVr) using the MitraClip in patients with exercise-induced secondary MR. METHODS AND RESULTS: Of the 200 consecutive patients with secondary MR who underwent exercise stress echocardiography, 46 (23%) that presented with exercise-induced secondary MR [i.e. increase in effective regurgitant orifice area (EROA) of ≥ 0.13 cm2] were enrolled in the present investigation. The composite endpoints of all-cause mortality and hospitalization for heart failure were evaluated. Of the 46 patients included in the current cohort, 19 (41%) underwent TMVr and 27 (59%) were medically managed (control group). Although the TMVr group tended to present with a greater EROA at rest (0.26 ± 0.10 vs. 0.20 ± 0.08 cm2, P = 0.047), there were no differences in the EROA changes during exercise between the two groups (0.18 ± 0.10 vs. 0.18 ± 0.04 cm2, P = 0.940). While the TMVr group reported a higher event-free survival rate after the 13-month follow-up period (log-rank P = 0.017), the Cox proportional-hazard analysis suggested the TMVr to be associated with clinical outcomes (hazard ratio: 0.419, P = 0.044). CONCLUSION: As opposed to the medical management, TMVr treatment was associated with a lower risk of composite endpoints in patients with exercise-induced secondary MR. Exercise stress echocardiography is considered to have played an important role in decision-making for secondary MR.
No takes yet. Share an insight, caveat, or question.
Izumo et al. (2020) conducted a cohort in Exercise-induced secondary mitral regurgitation (n=46). Transcatheter mitral valve repair (TMVr) using the MitraClip vs. Medical management was evaluated on Composite of all-cause mortality and hospitalization for heart failure (HR 0.419, p=0.044). Transcatheter mitral valve repair was associated with a lower risk of all-cause mortality and heart failure hospitalization compared to medical management (HR 0.419, P=0.044).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: